Companies › CRSP

CRISPR THERAPEUTICS AG (CRSP)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001674416 · EDGAR filings · Updated 2026-07-27

CRISPR THERAPEUTICS AG (CRSP) has reported institutional ownership of 80.0%, with 488 institutional managers holding positions valued at $3.67B per the latest 13F reporting period.

Filings this week (1)

• 2026-07-27 — SCHEDULE 13G/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-09 — Insider transaction reported (Form 4)
• 2026-06-09 — Insider transaction reported (Form 4)
• 2026-06-09 — Insider transaction reported (Form 4)
• 2026-06-09 — Insider transaction reported (Form 4)
• 2026-06-09 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CRISPR THERAPEUTICS AG has 488 institutional holders and institutional ownership of 80.0%.

Insider activity

Insiders reported 55 transactions (5 buys, 27 sells) across 7 reporting insiders, with a net reported value of $35.1M.

Related companies

TANGO THERAPEUTICS INC (TNGX) · LIVANOVA PLC SHS (LIVN) · EDGEWISE THERAPEUTICS INC (EWTX) · ACADIA PHARMACEUTICALS INC COM (ACAD) · TWIST BIOSCIENCE CORP (TWST) · TRANSMEDICS GROUP INC (TMDX)